Share This Page
Details for Patent: 5,501,236
✉ Email this page to a colleague
Summary for Patent: 5,501,236
| Title: | Nicotine-impermeable container and method of fabricating the same | ||||||||||||||||||||||||
| Abstract: | The present invention relates to a nicotine-impermeable container and a method for fabricating same. Additionally, the invention relates to a nicotine inhaling device which allows a user to ingest nicotine vapors orally. The nicotine inhaling device of the present invention is primarily directed to a device which can be used as a smoking cessation aid. | ||||||||||||||||||||||||
| Inventor(s): | Ira Hill, Bengt E. Malmborg, Ronald G. Oldham, James E. Turner, Michael P. Ellis, Sven-Bo/ rje Andersson | ||||||||||||||||||||||||
| Assignee: | McNeil AB | ||||||||||||||||||||||||
| Application Number: | US08/400,595 | ||||||||||||||||||||||||
|
Patent Claim Types: see list of patent claims | Use; Formulation; Compound; Delivery; | ||||||||||||||||||||||||
| Patent landscape, scope, and claims: | United States Patent 5,501,236: Nicotine Delivery System With Shelf-Life-Extending BarrierUS Drug Patent 5,501,236 claims a nicotine delivery system designed to maintain nicotine integrity for extended shelf life by enclosing a measured nicotine reservoir within a self-sealed, nicotine-impermeable, heat-sealed barrier made from a copolymer of acrylonitrile and methyl acrylate, optionally reinforced with metal foil and maintained in an oxygen-free environment using inert gas (nitrogen). The core IP value is the combination of (i) barrier polymer chemistry and (ii) packaging architecture that blocks nicotine migration and oxygen ingress. What does claim 1 actually require (scope lock-in)?Claim 1 elements (minimum infringement checklist)Claim 1 depends on all three structural/functional requirements below:
Scope implications
How do dependent claims narrow the protected space?Claim 2: Oxygen-free environment inside the barrier
Scope effect: Adds internal atmosphere constraints. A system with ambient oxygen inside the barrier does not map. Claim 3: Oxygen-free maintained by inert gas
Scope effect: Requires an inert gas generation/containment approach, not just a pre-evacuation and backfill at packaging. The language “maintained by” focuses on the in-use atmosphere over shelf life. Claim 4: Inert gas is nitrogen
Scope effect: Further limits the inert gas to nitrogen specifically (if litigated as written). Claim 5: Metal foil reinforcement
Scope effect: Adds a layered barrier structure: polymer barrier + adhered metal foil on the outer surface of that polymer barrier layer. Claim 6: Foil is aluminum
Scope effect: Narrows metal foil to aluminum. Claim 7: Reservoir formulation architecture
Scope effect: Adds reservoir construction: porous plug and solution containing at least nicotine free-base (not solely nicotine salt). What is the practical “claim map” for infringement risk?Literal claim 1 requires all of the following:
Common design variations and whether they align
What does the “essentially of” language do to polymer scope?The claim uses “formed essentially of” rather than a strict “consists of.” That typically allows minor components or processing aids that do not change the barrier’s essential copolymer identity. For enforcement planning, the critical question becomes whether an accused barrier layer contains the acrylonitrile + methyl acrylate copolymer as the dominant barrier-forming component and whether other components materially replace it. Business takeaway: the claim targets a specific barrier copolymer family, but leaves room for blend/processing flexibility. How the oxygen-free dependent claims affect packaging strategy
Nitrogen limitation in claim 4A system that uses argon, helium, or another inert gas may avoid claim 4 while still potentially meeting claim 3 if it qualifies as “gas inert to nicotine.” Claim 4 narrows only if the nitrogen requirement is treated as literal and not substituted by equivalents. How claim 5-6 layered barriers change the technology and freedom-to-operate pictureClaim 5 adds metal foil adhered to the outer surface of the polymer barrier layer. This shifts infringement from “polymer-only packaging” into “polymer + foil laminates.”
For FTO, the higher-risk zone is products using:
How claim 7 changes formulation and product architecture scopeClaim 7 restricts reservoir to a porous polymer plug charged with a solution containing nicotine free-base. Scope effects
Claim 7 narrows to a specific internal nicotine carrier architecture. What is the likely “center of gravity” of the patent?Across the claim set, the center of gravity sits in claim 1:
Dependent claims layer on:
This means the strongest enforcement and licensing position is likely on the barrier design and seal method, with dependent claims expanding value when products adopt those added shelf-life protections. Patent landscape analysis: where this claim set sits in the competitive spaceBecause only the claim text is provided, this analysis focuses on scope-positioning rather than a citation-based mapping of other patents. The landscape can still be meaningfully framed in terms of how competitors typically protect the shelf life of nicotine: 1) Competitors protecting shelf life by barrier chemistryCommon alternatives include oxygen barrier polymers and nicotine-migration control materials that are not acrylonitrile/methyl acrylate copolymers. Under the provided claim language, those alternatives:
2) Competitors protecting shelf life by packaging process and sealingHeat sealing is explicitly required in claim 1. Competitors using other closure technologies:
3) Competitors using metal foil or metallized layersMany commercial barriers incorporate foil for oxygen control or mechanical strength. Under the provided claims:
4) Competitors using oxygen-free headspaceInert gas blanketing is common in packaging. Under claims 2-4:
5) Competitors using different nicotine reservoir architecturesPorous polymer plugs loaded with nicotine free-base are a narrower internal architecture. Many products use salt forms, gels, or capillary matrices. Claim 7 therefore carves out a specific reservoir construction approach. Scope summary by claim layer (what a design must have to be caught)
Key Takeaways
FAQs
References[1] United States Patent 5,501,236, “Nicotine delivery system with an extended shelf life” (claims provided in prompt). More… ↓ |
Drugs Protected by US Patent 5,501,236
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,501,236
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 174805 | ⤷ Start Trial | |||
| Australia | 642506 | ⤷ Start Trial | |||
| Australia | 8002791 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
